Ufovax & TSRI Sign a License Agreement March 21, 2018 Ufovax and TSRI signed a License Agreement, under which TSRI granted Ufovax an exclusive global right on its technology – “UFO trimer on nanoparticle (UFOTON) as HIV vaccine”.
